Literature DB >> 34247983

Waksman In-Stent Restenosis Classification: A Mechanism-Based Approach to the Treatment of Restenosis.

Evan Shlofmitz1, Brian C Case1, Yuefeng Chen1, Chava Chezar-Azerrad1, Hayder Hashim1, Hector M Garcia-Garcia1, Gary S Mintz1, Ron Waksman2.   

Abstract

Despite contemporary advances in stent technology, in-stent restenosis (ISR) remains a common issue following percutaneous coronary intervention. A novel classification system based on the underlying mechanism of action of restenosis was recently introduced. The Waksman In-Stent Restenosis Classification characterizes different patterns of ISR to best delineate the type of restenosis and help guide treatment. Intravascular imaging with either intravascular ultrasound or optical coherence tomography allows for real-time evaluation of ISR. We herein provide an illustrative review of the Waksman In-Stent Restenosis Classification.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Drug-eluting stent; In-stent restenosis; Intravascular imaging; Percutaneous coronary intervention

Mesh:

Year:  2021        PMID: 34247983     DOI: 10.1016/j.carrev.2021.06.004

Source DB:  PubMed          Journal:  Cardiovasc Revasc Med        ISSN: 1878-0938


  3 in total

1.  Histopathological findings of late-phase restenosis after directional coronary atherectomy with drug-coated balloon angioplasty: a case report.

Authors:  Hiroyuki Yamamoto; Takuo Emoto; Shintaro Takeda; Tomofumi Takaya
Journal:  Eur Heart J Case Rep       Date:  2022-06-28

Review 2.  Intravascular imaging in coronary stent restenosis: Prevention, characterization, and management.

Authors:  Amr Abouelnour; Tommaso Gori
Journal:  Front Cardiovasc Med       Date:  2022-08-09

3.  Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia.

Authors:  Dai Sik Ko; Junho Kang; Hye Jin Heo; Eun Kyoung Kim; Kihun Kim; Jin Mo Kang; YunJae Jung; Seung Eun Baek; Yun Hak Kim
Journal:  Int J Biol Sci       Date:  2022-08-08       Impact factor: 10.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.